INVO Bioscience Inc (INVO)
0.9249
-0.01
(-0.66%)
USD |
NASDAQ |
May 03, 16:00
0.92
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Shareholders Equity (Quarterly): 0.8928M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.8928M |
| September 30, 2023 | 0.3728M |
| June 30, 2023 | -1.706M |
| March 31, 2023 | 0.0885M |
| December 31, 2022 | -0.9776M |
| September 30, 2022 | 1.287M |
| June 30, 2022 | 3.356M |
| March 31, 2022 | 5.590M |
| December 31, 2021 | 7.311M |
| September 30, 2021 | 2.595M |
| June 30, 2021 | 4.358M |
| March 31, 2021 | 5.598M |
| December 31, 2020 | 5.743M |
| September 30, 2020 | -3.902M |
| June 30, 2020 | -3.598M |
| March 31, 2020 | -4.435M |
| December 31, 2019 | -3.714M |
| Date | Value |
|---|---|
| September 30, 2019 | -3.761M |
| June 30, 2019 | -3.159M |
| March 31, 2019 | -3.102M |
| December 31, 2018 | -2.724M |
| September 30, 2018 | -4.428M |
| June 30, 2018 | -4.134M |
| March 31, 2018 | -4.908M |
| December 31, 2017 | -4.992M |
| September 30, 2017 | -4.880M |
| June 30, 2017 | -4.804M |
| March 31, 2017 | -4.715M |
| December 31, 2016 | -4.618M |
| September 30, 2016 | -4.341M |
| June 30, 2016 | -4.130M |
| March 31, 2016 | -3.938M |
| December 31, 2015 | -3.757M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.435M
Minimum
Mar 2020
7.311M
Maximum
Dec 2021
0.6285M
Average
0.3728M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 38.60B |
| Perspective Therapeutics Inc | 75.18M |
| Xtant Medical Holdings Inc | 51.35M |
| Asensus Surgical Inc | 33.41M |
| Catheter Precision Inc | 21.19M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.89M |
| Total Liabilities (Quarterly) | 20.00M |
| Debt to Equity Ratio | 3.096 |
| Current Ratio | 0.1533 |
| Net Debt Paydown Yield | -16.43% |